The Pennant (US:PNTG) ZACKS·2025-02-26 15:15Core Viewpoint - Analysts project that The Pennant Group, Inc. (PNTG) will report quarterly earnings of $0.25 per share, reflecting a 13.6% increase year over year, with revenues expected to reach $186.81 million, a 28% increase from the same quarter last year [1]. Earnings Estimates - Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter, indicating that analysts have not changed their initial forecasts during this period [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - The consensus estimate for 'Revenue- Total home health and hospice services' is projected at $141.45 million, representing a 32.3% increase from the year-ago quarter [5]. - Analysts estimate 'Revenue- Senior living services' to reach $45.37 million, suggesting a 16.1% year-over-year change [5]. - The average prediction for 'Revenue- Home health and hospice services- Home care and other' is $12.33 million, indicating an 88.1% increase from the prior-year quarter [6]. - The consensus estimate for 'Revenue- Home health and hospice services- Hospice' is $65.33 million, reflecting a 20.1% increase from the year-ago quarter [6]. - Analysts project 'Revenue- Home health and hospice services- Home health' to arrive at $63.79 million, indicating a year-over-year change of 38.9% [7]. Stock Performance - Over the past month, shares of The Pennant Group have returned -3.4%, compared to the Zacks S&P 500 composite's -2.3% change [7]. - Currently, PNTG holds a Zacks Rank 3 (Hold), suggesting that its performance may align with the overall market in the near future [7].